Breast-feeding and Transmission of HIV-1

Journal of Acquired Immune Deficiency Syndromes

Volumn 35, Issue 2, 2004, Pages 196-202

  John Stewart, Grace ^a   Mbori Ngacha, Dorothy ^b   Ekpini, Rene ^c   Janoff, Edward N ^d   Nkengasong, John ^e,f   Read, Jennifer S ^g   Van De Perre, Phillippe ^h   Newell, Marie Louise ⁱ  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d UNIVERSITY OF MINNESOTA   (United States)

^e Project RETRO CI Abidjan   (Côte d’Ivoire)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^h MONTPELLIER UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Breastfeeding; Mechanisms; Mother to child transmission; Postnatal transmission; Risk factors

Indexed keywords

ABACAVIR; ANTIBODY; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; DIDANOSINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; LAMIVUDINE; MONOCLONAL ANTIBODY; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; STAVUDINE; TENOFOVIR; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTIFICIAL MILK; BREAST FEEDING; CELL FREE SYSTEM; CROSS RESISTANCE; DELIVERY; DISEASE ASSOCIATION; FEMALE; GENETIC SELECTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTESTINE MUCOSA; LACTATION; MONOTHERAPY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROBABILITY; PROPHYLAXIS; REVIEW; RISK FACTOR; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS MUTANT; VIRUS MUTATION; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BREAST FEEDING; DISEASE TRANSMISSION, VERTICAL; DRUG RESISTANCE, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MILK, HUMAN; RISK FACTORS;

EID: 1642458238     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200402010-00015     Document Type: Review

References (53)

1. Nduati R, John G, Ngacha DA, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomised clinical trial. JAMA. 2000;283:1167-1174.
2. Leroy V, Karon JM, Alioum A, et al. 24-month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa. AIDS. 2002;16:631-641.
3. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet. 1999;353:773-780.
4. Wiktor SZ, Ekpini E, Karon JM, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial. Lancet. 1999;353:781-785.
5. Dabis F, Msellati P, Meda N, et al. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo controlled multicentre trial. Lancet. 1999;353:786-792.
6. Dunn D, Newell ML, Ades A, et al. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 1992;340:585-588.
7. Embree JE, Njenga S, Datta P, et al. Risk factors for postnatal mother-to-child transmission of HIV-1. Paper presented at: Second Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants: September 1-6, 1999; Montreal, Canada. Abstracts: 201.
8. Lewis P, Nduati R, Kreiss JK, et al. Cell-free human immunodeficiency virus type 1 in breast milk. J Infect Dis. 1998;177:34-39.
9. Semba RD, Kumwenda NI, Hoover DR, et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis. 1999;180:93-98.
10. Willumsen JF, Filteau SM, Coutsoudis A, et al. Breastmilk RNA viral load in HIV-infected South African women: effects of subclinical mastitis and infant feeding. AIDS. 2003;17:407-414.
11. Leroy V, Karon JM, Alioum A, et al. Postnatal transmission of HIV-1 after a maternal short-course zidovudine peripartum regimen in West Africa: a pooled analysis of two randomised clinical trials. AIDS. 2003; 17:1493-1501.
12. John GC, Nduati RW, Mbori-Ngacha D, et al. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding and breast infections. J. Infect Dis. 2001;183:206-212.
13. Willumsen JF, Newell ML, Filteau SM, et al. Variation in breastmilk HIV-1 viral load in left and right breasts during the first 3 months of lactation. AIDS. 2001;15:1896-1897.
14. Richardson BA, John-Stewart GC, Hughes JP, et al. Breast-milk infectivity in human immunodeficiency virus type-1-infected mothers. J Infect Dis. 2003;127:736-740.
15. Ekpini E, Wiktor SZ, Satten GA, et al. Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire. Lancet. 1997;349:1054-1059.
16. Fawzi WW, Msamanga GI, Hunter D, et al. Randomized trial of vitamin supplements in relation to transmission of HV-1 through breastfeeding and early child mortality. AIDS. 2002;16:1935-1944.
17. Nicoll A, Newell ML, Peckham C, et al. Infant feeding and HIV-1 infection. AIDS. 2000;14(suppl 3):S57-S74.
18. Coutsoudis A, Pillay K, Kuhn L, et al. Methods of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa. AIDS. 2001;15:379-387.
19. Rollins N, Filteau SM, Coutsoudis A, et al. Feeding mode, intestinal permeability and neopterin excretion: a longitudinal study in infants of HIV infected South African women. J Acquir Immune Defic Syndr. 2001;28: 132-138.
20. Miotti PG, Taha TE, Kumwenda NI, et al. HIV transmission through breastfeeding: a study in Malawi. JAMA. 1999;282:744-749.
21. Leroy V, Newell ML, Dabis F, et al. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Lancet. 1998;352:597-600.
22. The Petra Study. Efficacy of the three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania. South Africa and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet. 2002;359: 1178-1186.
23. Karlsson K, Massawe A, Urassa E, et al. Late postnatal transmission of human immunodeficiency virus type 1 infection from mothers to infants in Dar es Salaam, Tanzania. Pediatr Infect Dis J. 1997;16:963-967.
24. Read JS, Newell ML, Leroy V, et al. Late postnatal transmission of HIV in breastfed children: an individual patient data meta-analysis (BHITS). Paper presented at: 10th Conference on Retrovirus and Opportunistic Infections: February 10-14, 2003. Abstract 97.
25. Coakley E, Gillis J, Hammer SM. Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine. AIDS. 2000;14:F9-F15.
26. Bangsberg D, Hecht F, Charlebois E, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357-366.
27. Harrigan R, Larder B. Extent of cross-resistance between agents used to treat HIV type 1 infection in clinically derived isolates. Antimicrob Agents Chemother. 2002;46:909-912.
28. Kane MA, Clements J, Hu D. Hepatitis B. In: Jamison DT, Mosley WH, Measham AR, et al., eds. Disease Control Priorities in Developing Countries. A World Bank Book. New York: Oxford University Press; 1993: 321-330.
29. Mandelbrot L, Landreau A, Rekacewicz C, et al. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA. 2001;285:2083-2093.
30. Chaowanachan T, Chotpitayasunondh T, Vanprapar N, et al. Resistance mutations following a single-dose intrapartum administration of nevirapine to HIV-infected Thai women and their infants receiving short course zidovudine. Paper presented at: 10th Conference on Retrovirus and Opportunistic Infections; February 10-14, 2003. Abstract 855.
31. Nolan M, Fowler MG, Mofenson L. Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance. J Acquir Immune Defic Syndr. 2002;30:216-229.
32. Eshlemann S, Mracna M, Guay LA, et al. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET012). AIDS. 2001;15:1951-1957.
33. Ekpini R, Nkenganson J, Sibailly T, et al. Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine. AIDS. 2002;16:625-630.
34. Becquart P, Chomont N, Roques P, et al. Compartmentalization of HIV-1 between breast milk and blood of HIV-infected mothers. Virology. 2002; 300:109-117.
35. Bomsel M. Trancytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med. 1997;3:42-47.
36. Bomsel M, Heyman M, Hocini H, et al. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity. 1998;9:277-287.
37. Witcomb J, Paxinos E, Huang W, et al. The presence of NAM is highly correlated with reduced susceptibility to all NRTI. Paper presented at: 9th Conference on Retrovirus and Opportunistic Infections (CROI); February 2002; Seattle. Abstract 569.
38. Frankel SS, Wenig BM, Burke AP, et al. Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science. 1996; 272:115-117.
39. Frankel SS, Tenner-Racz K, Racz P, et al. Active replication of HIV-1 at the lymphoepithelial surface of the tonsil. Am J Pathol. 1997, 151:89-96. 1997.
40. Stahl-Hennig C, Steinman RM, Tenner-Racz K, et al. Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. Science. 1999;285:1261-1265.
41. Meng G, Wei X, Selters MT, et al. Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nat Med. 2002;8:150-156.
42. Poles MA, Elliott J, Taing P, Anton PA, Chen IS. A preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection. J Virol. 2001;75(18):8390-8399.
43. Kage A, Shoolian E, Rokos K, Ozel M, Nuck R, Reutter W, Kottgen E, Pauli G. Epithelial uptake and transport of cell-free human immunodeficiency virus type 1 and gp120-coated microparticles. J Virol. 1998;72: 4231-4236.
44. McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, and Wahl SM. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest. 1995;96:456.
45. Pillay K, Coutsoudis A, Agadzi-Naqvi AK, Kuhn L, Coovadia HM, Janoff EN. Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission. J Invect Dis. 2001;18:653-656.
46. Farquhar C, Thomas C, VanCott TC, et al. Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk. J Infect Dis. 2002;186: 1173-1176.
47. Becquart P, Hocini H, Levy M, et al. Secretory anti-human immunodeficiency virus (HIV) antibodies to colostrum and breastmilk are not a major determinant of the protection of early postnatal transmission of HIV. J Infect Dis. 2000;181:532-539.
48. Janoff EN, Scamurra RW, Sanneman TC, Eidman K, Thurn JR. Human immunodeficiency virus type 1 and mucosal humoral defense. J Infect Dis. 1999;179(Suppl 3):S475-S479.
49. Alfsen A, Iniguez P, Bouguyon E, Bomsel M. Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1. J Immunol. 2001;661:6257-6256.
50. Sabbaj S, Edwards BH, Ghosh MK, Semrau K, Cheelo S, Thea DM, Kuhn L, Ritter GD, Mulligan MJ, Goepfert PA, Aldrovandi GM. Human immunodeficiency virus-specific CD8(+) T cells in human breast milk. J Virol. 2002;76:7365-7373.
51. Veazey RS, Shattock RJ, Pope M, Kirijan JC, Jones J, Hu Q, Ketas T, Marx PA, Klasse PJ, Burton DR, Moore JP. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat Med. 2003;9:343-346.
52. WHO/UNICEF/UNAIDS. New Data on the Prevention of Mother-to-Child Transmission of HIV and Their Policy Implications: Conclusions and Recommendations. Geneva: WHO; 2000.
53. United Nations. Declaration of Commitment on HIV/AIDS. United Nations General Assembly Special Session on HIV/AIDS, New York 25-27 June 2001;no 54.